


Diagnos Inc.: DIAGNOS Announces Memorandum of Understanding with ISee3D Inc.
BROSSARD, QUEBEC--(Marketwire - Sept. 29, 2009) - DIAGNOS inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), a leader in the use of artificial intelligence and advanced knowledge extraction techniques, announces today that it has signed a Memorandum of Understanding, and associated Non-Disclosure Agreement with ISee3D Inc., a Canadian technology Company that holds patents and is developing a single lens camera technology capable of capturing on-the-fly, high definition (HD) broadcast quality 3D video.
"We believe that by working together we can jointly leverage each other's strengths in our respective technologies to offer enhanced diagnostic and analytic applications to our clients" said Andre Larente, President of DIAGNOS.
"We are exploring potential synergies in the application of DIAGNOS competencies to Isee3D's stereoscopic images and videos in several areas of joint interest including: diagnostic analytics, pattern recognition, and image interpolation" said Dwight Romanica Chairman and CEO of ISee3D.
Additionally, ISee3D plans to take advantage of DIAGNOS' competency in software design and development for a variety of Isee3D initiatives.
About ISee3D Inc.
ISee3D Inc. (TSX VENTURE:ICT) owns certain patented technology which provides for the capture of stereoscopic (3D) images through a single lens. The company's technology has broad application in several markets including the home entertainment industry, consumer electronics, and imaging devices of all sorts including microscopes, endoscopes as well as more sophisticated medical imaging systems.
About DIAGNOS
Founded in 1998, DIAGNOS is a publicly traded Canadian corporation (TSX VENTURE:ADK), with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision-making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including healthcare, natural resources, and entertainment.
The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this press release.
For further information, please visit our website at [ www.diagnos.com ] or the SEDAR website at [ www.sedar.com ]. You may also contact our investor relations representative.